Komipharm International Co., Ltd.
돼지 및 가금류용 수의학 API 및 완제 주사제를 생산하며 70개국에 수출하고 있습니다.
코미팜은 아목시실린, 플로르페니콜, 틸미코신 주사제와 용해성 분말 등의 동물용 의약품을 생산합니다. GMP 인증 공장은 라틴 아메리카와 동남아시아의 동물 의약품 유통업체와 대규모 통합업체에 제품을 공급합니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Siheung, South Korea
- Website
- komipharm.com
- Categories
- 수의학 제품 및 동물 건강
- Markets
- 브라질, 베트남, 인도네시아, 필리핀
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- product-authorised-for-sale (green), checked 2026-08-20 NAFDAC Greenbook, Nigeria - register of authorised products (manufacturer named on the authorisation)
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-09 Domain registry record
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)